author-photo

Veronique Sardnal

5

Papers

111

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

2016 Leukemia
Show All
- Source
- Cite
- Save
Citations (77)
P-133 A single nucleotide polymorphism in CRBN gene as a biomarker of response to treatment with lenalidomide in MDS without del5q

2013 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (0)
A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q)

2013 Leukemia
Show All
- Source
- Cite
- Save
Citations (25)
A randomized study of lenalidomide (LEN) with or without EPO in RBC transfusion dependent (TD) IPSS low and int-1 (lower risk) myelodysplastic syndromes (MDS) without del 5q resistant to EPO.

2013 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)